Syncom Formulations (India) Limited (BOM:524470)
13.95
+0.15 (1.09%)
At close: Apr 16, 2026
BOM:524470 Revenue
Syncom Formulations (India) had revenue of 1.15B INR in the quarter ending December 31, 2025, a decrease of -9.72%. This brings the company's revenue in the last twelve months to 5.03B, up 28.65% year-over-year. In the fiscal year ending March 31, 2025, Syncom Formulations (India) had annual revenue of 4.65B with 76.55% growth.
Revenue (ttm)
5.03B
Revenue Growth
+28.65%
P/S Ratio
2.58
Revenue / Employee
6.76M
Employees
744
Market Cap
12.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.65B | 2.02B | 76.55% |
| Mar 31, 2024 | 2.63B | 391.33M | 17.45% |
| Mar 31, 2023 | 2.24B | 45.91M | 2.09% |
| Mar 31, 2022 | 2.20B | -251.42M | -10.27% |
| Mar 31, 2021 | 2.45B | 392.94M | 19.12% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| I G Petrochemicals | 18.81B |
| Andhra Paper | 15.82B |
| Punjab Chemicals and Crop Protection | 10.24B |
| TTK Healthcare | 8.30B |
| India Motor Parts & Accessories | 8.15B |
| Ultramarine & Pigments | 7.71B |
| Centrum Capital | 7.57B |
| Hester Biosciences | 3.16B |